| (2S)-Octyl-α-hydroxyglutarate |
(2S)-OCTYL-伪-HYDROXYGLUTARATE |
1391194-64-1 |
| CBB1003 |
1379573-88-2 |
1379573-88-2 |
| YH239-EE |
[N/A] |
1364488-67-4 |
| 2-Fluoro-4'-[[4-(4-pyridinylMethyl)-1-piperazinyl]Methyl]-α,α-bis(trifluoroMethyl)-[1,1'-biphenyl]-4-Methanol |
化合物 T16929 |
1359164-11-6 |
| Ischemin |
Ischemin |
1357059-00-7 |
| OG-L002 |
OG-L002 |
1357302-64-7 |
| Mutant IDH1-IN-1 |
MUTANT IDH1-IN-1 |
1355326-21-4 |
| Aldose reductase-IN-1 |
1355612-71-3 |
1355612-71-3 |
| CID-49830258 |
ML240 |
1346527-98-7 |
| Arginase inhibitor 1 |
(ALPHAR)-ALPHA-氨基-ALPHA-(4-硼酸基丁基)-1-哌啶丁酸 |
1345808-25-4 |
| YL-0919 |
CS-2407 |
1339339-18-2 |
| VTX-27 |
1321924-70-2 |
1321924-70-2 |
| HG6-64-1 |
CS-1301 |
1315329-43-1 |
| NVP BGJ398 phosphate |
NVP BGJ398 磷酸盐 |
1310746-10-1 |
| ENMD-2076 (Tartrate) |
ENMD-2076 |
1291074-87-7 |
| Lys-SMCC-DM1 |
Lys-SMCC-DM1 |
1281816-04-3 |
| ROCK-II inhibitor |
(3S)-N-[2-[2-(二甲基氨基)乙氧基]-4-(1H-吡唑-4-基)苯基]-3,4-二氢-6-甲氧基-2H-1-苯并吡喃-3-甲酰胺 |
1273579-40-0 |
| YLF-466D |
3-[[(3E)-3-[(4-氯苯基)苯基亚甲基]-2,3-二氢-2-氧代-1H-吲哚-1-基]甲基]苯甲酸 |
1273323-67-3 |
| BenzaMide, 4-(4-ethyl-5-fluoro-2-hydroxyphenoxy)-3-fluoro- |
4-(4-乙基-5-氟-2-羟基苯氧基)-3-氟苯甲酰胺 |
1269055-85-7 |
| (S)-2-nitro-6-((6-(4-(trifluoroMethoxy)phenyl)pyridin-3-yl)Methoxy)-6,7-dihydro-5H-iMidazo[2,1-b][1,3]oxazine |
TBA-354 |
1257426-19-9 |
